Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5536908 | Vaccine | 2017 | 8 Pages |
Abstract
We predict a sustained and substantial decline in IPD through PCV vaccination and that the current regimen is insufficient to fully eliminate vaccine-serotype circulation in the model. We show that the observed impact is likely to be sustained despite waning effects of the catch-up campaign.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
John Ojal, Stefan Flasche, Laura L. Hammitt, Donald Akech, Moses C. Kiti, Tatu Kamau, Ifedayo Adetifa, Markku Nurhonen, J. Anthony G. Scott, Kari Auranen,